bioMérieux is a global leader in in vitro diagnostics, specializing in the development and production of diagnostic solutions for clinical and industrial applications. Founded in 1963 by Alain Mérieux, the company has a rich history of innovation in microbiology, immunoassays, and molecular biology. They generate revenue by providing diagnostic tools and services to healthcare providers, laboratories, and the food and pharmaceutical industries. Notable for their pioneering work in infectious disease diagnostics, bioMérieux continues to advance public health through cutting-edge technology and a commitment to quality and reliability.